Drug-Induced Hypertension

被引：23

作者：

Foy, Matthew C. ^{[1
]}

Vaishnav, Joban ^{[2
]}

Sperati, Christopher John ^{[3
]}

机构：

[1] Louisiana State Univ, Hlth Sci Ctr, Div Nephrol, 5246 Brittany Dr, Baton Rouge, LA 70808 USA

[2] Johns Hopkins Univ, Sch Med, Div Cardiol, 600 N Wolfe St, Baltimore, MD 21287 USA

[3] Johns Hopkins Univ, Sch Med, Div Nephrol, 1830 East Monument St,Room 416, Baltimore, MD 21287 USA

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2019年 / 48卷 / 04期

关键词：

Drug-induced hypertension; Secondary hypertension; Polypharmacy; ENDOTHELIAL GROWTH-FACTOR; KIDNEY-TRANSPLANT RECIPIENTS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ANGIOTENSIN SYSTEM BLOCKADE; BLOOD-PRESSURE; NITRIC-OXIDE; ARTERIAL-HYPERTENSION; ORAL-CONTRACEPTIVES; RENAL-FUNCTION; ERYTHROPOIETIN;

D O I：

10.1016/j.ecl.2019.08.013

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Untoward side effects of pharmaceuticals can result in considerable morbidity and expense to the health care system. There is likely a sizable fraction of the hypertensive population with disease either induced or exacerbated by polypharmacy. The elevation of blood pressure in drug-induced hypertension occurs through a variety of mechanisms, most notably, sodium and fluid retention, activation of the renin-angiotensin-aldosterone system, alteration of vascular tone, or a combination of these pathways. Recognition of common medications causing drug-induced hypertension is important to effectively control blood pressure. The epidemiology, pathophysiology, and management of these agents are discussed.

引用

页码：859 / +

页数：16

共 50 条

[41] Drug-induced hypertension: Know the problem to know how to deal with it
Masi, Stefano
Uliana, Monica
Gesi, Marco
Taddei, Stefano
Virdis, Agostino
VASCULAR PHARMACOLOGY, 2019, 115 : 84 - 88
[42] Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management
Correale, Michele
Tricarico, Lucia
Grazioli, Davide
Formica, Ennio Sascia
Petrucci, Rossella
Persichella, Paola
Di Biase, Matteo
Brunetti, Natale Daniele
CARDIOVASCULAR DRUGS AND THERAPY, 2019, 33 (06) : 725 - 738
[43] Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management
Michele Correale
Lucia Tricarico
Davide Grazioli
Ennio Sascia Formica
Rossella Petrucci
Paola Persichella
Matteo Di Biase
Natale Daniele Brunetti
Cardiovascular Drugs and Therapy, 2019, 33 : 725 - 738
[44] "Anagrelide-induced pulmonary arterial hypertension": a rare case of drug-induced pulmonary arterial hypertension
Sumimoto, Keiko
Taniguchi, Yu
Matsuoka, Yoichiro
Onishi, Hiroyuki
Emoto, Noriaki
Hirata, Ken-ichi
PULMONARY CIRCULATION, 2019, 9 (04)
[45] DRUG-INDUCED DISEASES - DRUG-INDUCED RESPIRATORY-DISEASE
GRANT, IWB
BRITISH MEDICAL JOURNAL, 1979, 1 (6170): : 1070 - 1071
[46] DRUG-INDUCED DISEASES - DRUG-INDUCED CARDIOVASCULAR-DISEASE
BRECKENRIDGE, AM
BRITISH MEDICAL JOURNAL, 1979, 1 (6166): : 793 - 795
[47] DRUG-INDUCED DISEASES - DRUG-INDUCED LIVER-DISEASE
KEELING, PWN
THOMPSON, RPH
BRITISH MEDICAL JOURNAL, 1979, 1 (6169): : 990 - 993
[48] Levofloxacin associated drug-induced intracranial hypertension revealed by a bulging fontanelle
Robinson, J.
Lyman, B. C.
Conard, C.
Dietrich, M. L.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 : S372 - S373
[49] Effect of aerosolized milrinone during drug-induced pulmonary hypertension in lambs
Gelvez, J
Fakioglu, H
Olarte, JL
Soliz, A
Totapally, BR
Torbati, D
PHARMACOLOGICAL RESEARCH, 2004, 50 (01) : 87 - 91
[50] The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension
Frank, H
Mlczoch, J
Huber, K
Schuster, E
Gurtner, HP
Kneussl, M
CHEST, 1997, 112 (03) : 714 - 721

← 1 2 3 4 5 →